S H Kelkar & Company Ltd Downgraded to Below Average Quality Amid Deteriorating Fundamentals

Financial Performance and Growth Trends

Over the past five years, S H Kelkar & Co. has delivered a sales growth rate of 12.37%, which, while positive, is modest compared to peers in the specialty chemicals sector. More concerning is the negative compound annual growth rate (CAGR) in EBIT of -6.83% over the same period, signalling operational pressures and margin compression. This contrasts sharply with industry leaders such as Navin Fluorine International and Himadri Speciality Chemicals, which maintain robust earnings growth and have retained good quality grades.

The company’s sales to capital employed ratio averages 0.99, indicating that asset utilisation is roughly at par with invested capital, but not generating significant excess returns. This metric, combined with the subdued EBIT growth, suggests that the firm is struggling to convert its capital base into profitable growth effectively.

Return Ratios Reflect Deterioration

Return on capital employed (ROCE) and return on equity (ROE) are critical indicators of a company’s efficiency and profitability. S H Kelkar & Co.’s average ROCE stands at 9.64%, while ROE is slightly lower at 9.04%. Both figures fall below the typical benchmarks for the specialty chemicals sector, where leading companies often report ROCE and ROE in the mid to high teens. This underperformance signals that the company is generating limited value for shareholders relative to its capital base.

Moreover, the consistency of these returns has come under scrutiny, contributing to the downgrade in quality grade. Investors increasingly favour companies with stable and predictable profitability, and S H Kelkar’s metrics suggest volatility and underwhelming returns.

Debt Levels and Financial Leverage

Debt metrics reveal a mixed picture. The average debt to EBITDA ratio is 2.89, which is moderately high and indicates a significant leverage burden. Net debt to equity averages 0.56, reflecting a capital structure with a meaningful proportion of debt financing. While not excessive, these levels limit financial flexibility and increase vulnerability to interest rate fluctuations and economic downturns.

On a positive note, the EBIT to interest coverage ratio averages 5.26, suggesting that the company currently generates sufficient earnings to cover interest expenses comfortably. However, the declining EBIT trend raises concerns about the sustainability of this coverage going forward.

Dividend Policy and Shareholder Composition

S H Kelkar & Co. maintains a low dividend payout ratio of 8.48%, indicating a conservative approach to returning cash to shareholders. This may reflect the company’s need to conserve capital amid operational challenges. Institutional holding is relatively low at 12.60%, and pledged shares stand at 8.30%, which may signal limited institutional confidence and some insider leverage risk.

Market Performance and Investor Sentiment

The share price of S H Kelkar & Co. closed at ₹121.85 on 19 May 2026, down 9.71% from the previous close of ₹134.95. The stock has been under significant pressure year-to-date, with a decline of 31.95%, substantially underperforming the Sensex’s 11.62% gain over the same period. Over the past year, the stock has lost 39.57%, while the Sensex rose 8.52%, highlighting the widening gap between the company’s performance and broader market trends.

Longer-term returns also paint a challenging picture. Over five years, the stock has declined 18.14%, whereas the Sensex has surged 50.05%. Over ten years, the divergence is even starker, with the stock down 46.51% compared to the Sensex’s 193% gain. This persistent underperformance reflects fundamental weaknesses and investor concerns about the company’s growth prospects and financial health.

Comparative Quality Assessment within Specialty Chemicals

Within the specialty chemicals sector, S H Kelkar & Co. now holds a below average quality grade, a downgrade from its previous average rating as of 15 May 2026. This contrasts with several peers who maintain good quality grades, including Navin Fluorine International, Himadri Speciality Chemicals, Deepak Nitrite, Sumitomo Chemical, and Fine Organic. Even companies rated average, such as Atul and Aarti Industries, outperform S H Kelkar in key metrics.

This relative positioning underscores the company’s deteriorating fundamentals and the challenges it faces in regaining investor confidence and operational momentum.

Outlook and Investor Considerations

The downgrade to a strong sell mojo grade with a score of 17.0 reflects a consensus view that S H Kelkar & Co. faces significant headwinds. The combination of declining earnings, subpar returns, moderate leverage, and weak market performance suggests that investors should exercise caution. The company’s ability to reverse these trends will depend on operational improvements, margin recovery, and prudent capital management.

Given the current below average quality grade and the stock’s sustained underperformance relative to the Sensex and sector peers, investors may prefer to explore higher-quality alternatives within the specialty chemicals space or other sectors offering better risk-reward profiles.

In summary, while S H Kelkar & Co. remains a player in the specialty chemicals industry, its deteriorating fundamentals and downgraded quality grade warrant a cautious stance. Monitoring upcoming quarterly results and strategic initiatives will be crucial to reassessing its investment potential.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →